Vaginal progesterone, but not 17α-hydroxyprogesterone caproate, has antiinflammatory effects at the murine maternal-fetal interface

OBJECTIVE: Progestogen (vaginal progesterone or 17-alpha-hydroxyprogesterone caproate [17OHP-C]) administration to patients at risk for preterm delivery is widely used for the prevention of preterm birth (PTB). The mechanisms by which these agents prevent PTB are poorly understood. Progestogens have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Obstet Gynecol
Main Authors: Furcron, Amy-Eunice, Romero, Roberto, Plazyo, Olesya, Unkel, Ronald, Xu, Yi, Hassan, Sonia S., Chaemsaithong, Piya, Mahajan, Arushi, Gomez-Lopez, Nardhy
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4729364/
https://ncbi.nlm.nih.gov/pubmed/26264823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2015.08.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados